Actym Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Actym Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors (NCT06336148) | Actym Therapeutics, Inc. | 2024-06-05 |
Track Actym Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.